Glenmark Pharmaceuticals Ltd share price logo

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

BSE: 532296

Mid Cap

Pharma Sector

₹2166.20

-14.40

(-0.66%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Glenmark Pharmaceuticals Stock Performance

as on June 5, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,161.00
    ₹2,216.20
    downward going graph

    0.24%

    Downside

    2.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,448.50
    ₹2,474.00
    downward going graph

    33.13%

    Downside

    14.21%

    Upside

    downward going graph

Glenmark Pharmaceuticals share price movements today

Previous Close
₹2,180.60
Open
₹2,191.90
Volume
5.13L
Upper Circuit
₹2,398.60
Lower Circuit
₹1,962.60
Day's Low - High
₹2,161.00 - ₹2,216.20
52 Week Low - High
₹1,448.50 - ₹2,474.00

Glenmark Pharmaceuticals Historical Returns

1 Month Return
-8.46 %
3 Month Return
+ 2.3 %
1 Year Return
+ 35.46 %
3 Year Return
+ 234.08 %
5 Year Return
+ 244.22 %

Glenmark Pharmaceuticals Fundamentals

as on June 5, 2026 at 4:01 pm IST

Market Cap

₹61,130.34 Cr

Return on Equity (ROE)

6.78

PE Ratio (TTM)

44.89

Return on capital employed (ROCE)

8.94

Industry PE ratio

46.11

Beta (LTM)

0.75

P/B Ratio

1.77

Dividend Yield

0.16

PEG Ratio

4.02

Quarterly Earnings Growth YOY

6779.45

EPS (TTM)

37.11

Book Value

313.6

Glenmark Pharmaceuticals Stock Valuation

as on June 5, 2026 at 4:01 pm IST

Glenmark Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-275.05x)

December 28, 2023

Today (44.89x)

June 5, 2026

Industry (46.11x)

June 5, 2026

Highest (95.94x)

September 14, 2023

LowHigh

Today’s Price to Earnings Ratio: 44.89x

Glenmark Pharmaceuticals Technical Analysis

Track how Glenmark Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish4
Bullish8
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.52
Bullish
CCI (20)
525.27
Bearish
RSI (14)
61.99
Neutral
Momentum (10)
3.2
Bearish
ADI (14)
21.28
Neutral
Ultimate Oscillator (7,14,28)
30.75
Neutral

Moving Averages

Name

Value

Action

SMA (20)
2166.19
Bullish
EMA (20)
2166.93
Bullish
VWMA (20)
2166.95
Bullish
SMA (50)
2167.54
Bullish
EMA (50)
2167.41
Bullish
SMA (200)
2173.68
Bearish
EMA (200)
2172.18
Bearish
KAMA (200)
2169.38
Bullish
DEMA (200)
2167.42
Bullish

Glenmark Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Glenmark Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Glenmark Pharmaceuticals Ltd image
Glenmark Pharmaceuticals Ltd
BUY61,130.3448.84%0.621,04713,321
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,492.47-2.63%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY15,509.455.04%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY6,906.47-3.36%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY13,642.4439.68%0.672441,515
See all

Market expectation of Glenmark Pharmaceuticals Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Glenmark Pharmaceuticals Stock’s Investor Sentiment and Interest

Investment in Glenmark Pharmaceuticals Ltd Shares on INDmoney has grown by 84.06% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:84.06% versus previous 30 day period

Search interest for Glenmark Pharmaceuticals Ltd Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:51% versus previous 30 day period

Glenmark Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
2,998.47
3,160.69
2,460.29
3,016.01
3,223.3
3,400.5
3,301.9
3,220.13
3,059.33
6,003.79
3,888
3,760.28
Other Income
19.72
120.43
164.18
797.54
31.49
39.42
31.13
11.69
26.44
200.63
44.47
189.08
Total Income
3,055.79
3,327.81
2,670.88
3,860.49
3,275.68
3,473.21
3,418.68
3,267.89
3,290.88
6,247.5
3,945.08
3,959.67
Expenses
2,650.74
3,070.52
2,792.07
3,005.39
2,655.97
2,831.88
2,787.32
3,068
3,007.15
5,072.44
3,215.2
3,381.39
Operating Profit
347.73
90.17
-331.78
10.62
567.33
568.62
514.58
152.13
52.18
931.35
672.8
378.89
Operating Profit Margin %
11.6%
2.85%
-13.49%
0.35%
17.6%
16.72%
15.58%
4.72%
1.71%
15.51%
17.3%
10.08%
Profit Before Interest, Tax and Depreciation
405.05
257.3
-121.2
855.1
619.71
641.33
631.36
199.89
283.73
1,175.06
729.88
578.28
Interest
111.61
121.46
134.34
148.56
39.58
48.48
52.29
66.71
58.23
66.46
41.43
42.6
Depreciation
142.04
141.45
147.08
151.34
117.79
120.28
122.74
125.21
129.93
141.2
154.45
147.91
Profit Before Tax
151.4
-5.61
-402.62
555.2
462.34
472.57
456.33
7.97
95.57
967.4
534
387.77
Tax Paid
-21.73
55.95
-71.8
1,769.47
122.09
118.09
108.29
3.59
48.6
356.97
130.77
86.45
Profit After Tax
173.13
-61.56
-330.82
-1,214.27
340.24
354.49
348.03
4.38
46.97
610.43
403.23
301.32
Total Net profit including share of profit / Loss from associate company
173.13
-61.56
-330.82
-1,214.27
340.24
354.49
348.03
4.38
46.97
610.43
403.23
301.32
EPS
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
14.29
10.68
Actual EPS
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
14.29
10.68
Adjusted EPS
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
14.29
10.68
Diluted EPS
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.62
14.28
10.68

Glenmark Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
8,972.23
9,705.08
10,397.23
10,806.03
12,174.2
11,431.94
11,635.46
13,145.84
16,711.4
Other Income
91.4
375.32
192.48
94.76
166.67
755.86
1,237.32
113.72
460.62
Total Income
9,194.47
10,240.79
10,833.45
11,038.69
12,471.58
12,339.1
13,050.42
13,435.46
17,443.13
Expenses
7,487.7
8,279.67
8,942.89
8,859.55
10,245.52
10,714.08
11,518.72
11,343.18
14,676.18
Operating Profit
1,484.53
1,425.41
1,454.34
1,946.48
1,928.68
717.86
116.74
1,802.66
2,035.22
Operating Profit Margin %
16.55%
14.69%
13.99%
18.01%
15.84%
6.28%
1%
13.71%
12.18%
Profit Before Interest, Tax and Depreciation
1,706.77
1,961.12
1,890.56
2,179.14
2,226.06
1,625.01
1,531.7
2,092.28
2,766.95
Interest
285.57
334.59
377.32
353.11
298.1
349.04
515.97
207.07
208.73
Depreciation
301.88
325.91
417.17
443.55
486.72
569.17
581.91
486.01
573.48
Profit Before Tax
1,119.32
1,300.62
1,096.07
1,382.48
1,441.24
706.8
433.82
1,399.2
1,984.74
Tax Paid
315.46
375.63
320.11
412.39
447.6
329.4
1,867.34
352.07
622.8
Profit After Tax
803.87
924.99
775.97
970.09
993.65
377.4
-1,433.52
1,047.14
1,361.95
Total Net profit including share of profit / Loss from associate company
803.87
924.99
775.97
970.09
993.65
377.4
-1,433.52
1,047.14
1,361.95
EPS
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
48.26
Actual EPS
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
48.26
Adjusted EPS
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
48.26
Diluted EPS
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.1
48.24

Glenmark Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
344.85
657.43
1,648.05
1,324.17
1,392.41
1,131.21
1,108.65
625.39
-265.44
-827.6
Cash Flow from Investing Activities
-950.06
-1,001.34
-1,002.56
-882.52
-773.75
-661.62
-315.74
-515.43
4,386.81
58
Cash Flow from Financing Activities
698.6
543.14
-468.49
-738.74
-444.65
-441.78
-463.11
75.27
-3,906.13
787.04
Net Cash Flow
93.39
199.24
176.99
-297.08
174
27.82
272.43
32.5
215.24
17.44

Glenmark Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
46.65%
46.65%
46.64%
46.65%
46.65%
46.65%
46.65%
46.65%
46.65%
46.65%
46.65%
DII
10.32%
10.92%
13.36%
13.92%
13.21%
13.85%
14.6%
17.64%
18.61%
20.09%
19.29%
FII
24.8%
23.71%
21.38%
20.98%
23.05%
23.51%
23.16%
20.62%
20.73%
19.2%
20.34%
Government
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
Public
18.2%
18.69%
18.58%
18.41%
17.06%
15.96%
15.56%
15.06%
13.97%
14.02%
13.68%
Total Outstanding Shares
28,21,68,156
28,21,68,156
28,21,88,156
28,21,88,156
28,21,88,156
28,21,88,156
28,21,88,156
28,22,00,809
28,22,00,809
28,22,00,809
28,22,00,809
Total Shareholders
2,32,685
2,09,931
1,99,451
1,92,630
1,93,949
1,95,059
1,92,724
1,90,210
1,98,789
2,01,584
1,96,105

Mutual Funds that own Glenmark Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Glenmark Pharmaceuticals.

Glenmark Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Glenmark Pharmaceuticals.

  • Glenmark Pharmaceuticals Ltd Earnings Results

    Glenmark Pharmaceuticals Ltd’s net profit jumped 6381.94% since last year same period to ₹301.41Cr in the Q4 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -25.25% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Glenmark Pharmaceuticals Ltd Dividends September,2025

    In the quarter ending June 2025, Glenmark Pharmaceuticals Ltd has declared dividend of ₹2.50 per share on 26 Sep 2025 - translating a dividend yield of 0.23%.

    Read More about Dividends

Indices Featuring Glenmark Pharmaceuticals Stock

Check stock indices that include Glenmark Pharmaceuticals.

Nifty MidSmallcap 400

₹20,347.85

-0.19 (▲38.05%)

NIFTY PHARMA

₹24,248.05

0.29 (▲70.10%)

BSE Healthcare

₹46,908.38

0.47 (▲217.95%)

Nifty Alpha 50

₹52,203.05

-0.18 (▲96.50%)

S&P BSE 250 LargeMidCap

₹10,409.87

-0.10 (▲10.74%)

Nifty LargeMidcap 250

₹16,117.50

-0.21 (▲33.75%)

Nifty Midcap 150

₹22,251.80

-0.29 (▲64.15%)

S&P BSE 150 MidCap

₹16,282.05

-0.10 (▲16.71%)

Nifty Healthcare

₹15,409.35

0.56 (▲86.20%)

Nifty 200

₹13,527.00

-0.17 (▲22.85%)

S&P BSE 400 MidSmallCap

₹12,140.63

-0.07 (▲8.76%)

S&P BSE Momentum

₹2,092.99

-0.01 (▲0.24%)

Nifty Midcap 100

₹60,754.90

-0.35 (▲211.75%)

Nifty 500

₹22,465.35

-0.14 (▲32.35%)

BSE 500

₹35,141.95

-0.10 (▲33.66%)

Insights on Glenmark Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 19.20% to 20.35% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GLENMARK has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, GLENMARK stock has moved up by 35.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.94K Cr → 3.95K Cr (in ₹), with an average increase of 0.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.0% return, outperforming this stock by 3.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 46.65% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 17.86% to 16.80% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 14.02% to 13.68% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 610.35 Cr → 301.41 Cr (in ₹), with an average decrease of 29.6% per quarter

Glenmark Pharmaceuticals Stock Futures & Options Contracts

View the latest movement in Glenmark Pharmaceuticals Futures & Options, including strike prices, expiry dates, and percentage changes.

Glenmark Pharmaceuticals Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
GLENMARK 30 Jun ₹2200 Call
June 30, 2026
₹2200
₹63
-8.6
-12.01%
GLENMARK 30 Jun ₹2300 Call
June 30, 2026
₹2300
₹29
-6.2
-17.61%
GLENMARK 30 Jun ₹2400 Call
June 30, 2026
₹2400
₹14
-2.85
-16.91%
GLENMARK 30 Jun ₹2240 Call
June 30, 2026
₹2240
₹45.55
-7.8
-14.62%

Glenmark Pharmaceuticals Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
GLENMARK 30 Jun Fut
June 30, 2026
-
₹2188.3
-9.01
-0.41%
GLENMARK 28 Jul Fut
July 28, 2026
-
₹2192.2
-13.68
-0.62%
GLENMARK 25 Aug Fut
August 25, 2026
-
₹2216.8
-11.81
-0.53%

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is an Indian pharmaceuticals company listed on the National Stock Exchange and Bombay Stock Exchange. Established in 1977, the company manufactures and distributes branded and generic formulations, active pharmaceutical ingredients (API’s) and biosimilars. It has 18 manufacturing facilities in India, 7 in the U.S., 1 in Brazil and 1 in Mexico that span across the world catering to global requirements. Glenmark has taken several steps towards achieving a healthy presence in the global markets. In addition to its product portfolio, Glenmark’s aggressive acquisition strategy and product launch activities have helped expand its market reach. The company has been awarded numerous accolades over the years, including consecutive years of being ranked amongst the top 1000 world pharmaceutical companies. It continues to be a frontrunner in providing quality and affordable healthcare solutions in India and abroad.

Revenue: ₹3,760.28Cr as on March 2026 (Q4 FY26)
Net Profit: ₹301.32Cr as on March 2026 (Q4 FY26)
Listing date: 07 Feb, 2000
Chairperson Name: Glenn Saldanha
OrganisationGlenmark Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOGlenn Saldanha
E-voting on sharesClick here to vote

FAQs

What is Glenmark Pharmaceuticals share price today?

Glenmark Pharmaceuticals share price today stands at ₹2166.2 as on at the close of the market. Glenmark Pharmaceuticals share today touched a day high of ₹2216.2 and a low of ₹2161.

What is the 52 week high and 52 week low range for Glenmark Pharmaceuticals share?

Glenmark Pharmaceuticals touched a 52 week high of ₹2474 and a 52 week low of ₹1448.5. Glenmark Pharmaceuticals share price today i.e. is closed at ₹2166.2, which is -12.44% down from its 52 week high and 49.55% up from its 52 week low.

What is Glenmark Pharmaceuticals's market capitalisation today?

Glenmark Pharmaceuticals market capitalisation is ₹61,130.34 Cr as on .

How to buy Glenmark Pharmaceuticals shares?

To buy Glenmark Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GLENMARK or Glenmark Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Glenmark Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Glenmark Pharmaceuticals trading volume today?

Glenmark Pharmaceuticals trading volume is 5.13L as on . This means that 5.13L shares of Glenmark Pharmaceuticals were bought and sold on the stock market during today's trading session.